<h1>LRRK2 Cohort Consortium Publications and Presentations</h1>
<p>A goal of the LRRK2 Cohort Consortium is to bring research groups together early on to share resources and results, speeding collective efforts to move LRRK2 toward practical therapeutic relevance for patients. MJFF catalogs publications and presentations associated with the Consortium here to facilitate such communication.</p>
<p>Researchers accessing resources from the Consortium are required to adhere to the <a href="/files/23July2015LRRK2-Cohort-Consortium-Publication-Policy.docx" class="orange">LRRK2 Publications Policy</a>, <a href="https://www.michaeljfox.org/files/MJFF%20LRRK2%20Cohort%20Consortium%20Data%20Use%20Agreement%20Final%20(May%2030,%202013).pdf" target="_blank">Data Use Agreement</a> and <a href="https://www.michaeljfox.org/files/MJFF%20LRRK2%20Cohort%20Consortium%20Biospecimen%20Use%20Policy%20Final%20(May%2030,%202013).pdf" class="orange">Biospecimens Use Agreement</a>, which requires that all publications be submitted for administrative review. Email <a href="mailto:resources@michaeljfox.org" class="orange" target="_top">resources@michaeljfox.org</a> to submit a publication for review.</p>
<div>
<p></p>
</div>
<h2>Primary Publications</h2>
<p>Reports, analyses and subsequent publications on studies identified by MJFF and the LRRK2 Cohort Consortium as fulfilling the primary objectives of the study</p>
<table class="studyDesignTable">
<tbody>
<tr>
<td style="width: 192px;"><strong>Paper Topic</strong></td>
<td style="width: 100px;"><strong>Writing Committee Lead</strong></td>
<td style="width: 200px;"><strong>Writing Committee Members</strong></td>
<td style="width: 125px;"><strong>Status</strong></td>
</tr>
<tr>
<td>Difference between iPD-LRRK2 PD</td>
<td><a href="https://www.michaeljfox.org/foundation/researchers.php?id=695">Connie Marras, MD, PhD</a></td>
<td>Alcalay, Duda, Fernandez, Ruiz, Saunders-Pullman, Tolosa, Waro</td>
<td>In Preparation</td>
</tr>
<tr>
<td>Premotor LRRK2 characteriziation</td>
<td><a href="https://www.michaeljfox.org/foundation/researchers.php?id=1132">Eduardo Tolosa, MD, PhD</a></td>
<td>Alcalay, Duda, Marras, Mondragon, Saunders-Pullman, Waro</td>
<td>In Preparation</td>
</tr>
</tbody>
</table>
<p class="h-divider mt30">Â </p>
<h2>Secondary Publications</h2>
<p>Publications from investigators who have accessed either clinical data or biospecimens or both from the LRRK2 Cohort Consortium</p>
<table class="studyDesignTable">
<tbody>
<tr>
<td style="width: 192px;"><strong>Paper Topic</strong></td>
<td style="width: 100px;"><strong>Writing Committee Lead</strong></td>
<td style="width: 200px;"><strong>Writing Committee Members</strong></td>
<td style="width: 125px;"><strong>Status</strong></td>
</tr>
<tr>
<td>Gait and motor symptoms in LRRK2 carriers</td>
<td><a href="https://www.michaeljfox.org/foundation/researchers.php?id=1278">Anat Mirelman, PhD</a></td>
<td>Aasly, Berg, Bressman, Chan, Marder, Tolosa</td>
<td>In Preparation</td>
</tr>
<tr>
<td>Analytic models in biomarker development</td>
<td><a href="https://www.michaeljfox.org/foundation/researchers.php?id=933">Rachel Saunders-Pullman, MD, MPH, MS</a></td>
<td>Mirelman</td>
<td>In Preparation</td>
</tr>
<tr>
<td>LRRK2 mutations and cancer risk</td>
<td><a href="https://www.michaeljfox.org/foundation/researchers.php?id=933">Rachel Saunders-Pullman, MD, MPH, MS</a></td>
<td>Aasly, Berg, Bressman, Chan, Marder, Tolosa</td>
<td>Published</td>
</tr>
<tr>
<td>Autonomic dysfunction in LRRK2 mutation carriers</td>
<td><a href="https://www.michaeljfox.org/foundation/researchers.php?id=1536">Tanya Gurevich, MD</a></td>
<td>Aasly, Bressman, Chan, Giladi, Marder, Mirelman, Tolosa</td>
<td>In Preparation</td>
</tr>
<tr>
<td>Neuropathological collection in LRRK2 mutation carriers</td>
<td><a href="https://www.michaeljfox.org/foundation/researchers.php?id=1259">Roy Alcalay, MD, MSc</a></td>
<td>Marras</td>
<td>In Preparation</td>
</tr>
</tbody>
</table>
